Skip to content

Ideal Dosage for Sedation of Obese Patients Undergoing Knee or Hip Arthroplasty Under Spinal Anesthesia

Ideal Dosage for Sedation of Obese Patients Undergoing Knee or Hip Arthroplasty Under Spinal Anesthesia - a Phase 4 Clinical Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05760534
Enrollment
110
Registered
2023-03-08
Start date
2023-03-06
Completion date
2025-11-25
Last updated
2025-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis Hip, Arthritis Knee

Brief summary

This study aims to compare ideal body weight- and total body weight-based dosage for remimazolam sedation of obese patients undergoing knee or hip arthroplasty under spinal anesthesia.

Interventions

DRUGRemimazolam

0.075 mg/kg Remimazolam will be loaded over 1 min, then continuously infused at 0.2-1.0 mg/kg/h based on ideal or total body weight

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to 79 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients scheduled for elective knee or hip arthroplasty under spinal anesthesia * BMI\>25 * American Society of Anesthesiologists (ASA) classification I, II, III

Exclusion criteria

* Patient refusal * Contraindication for spinal anesthesia * Contraindication for remimazolam infusion * History of hypersensitivity to remimazolam * History of chronic use of benzodiazepine or opioid * Baseline MOAA/S score of 4 or lower * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Incidence of intraoperative respiratory depressionFrom entrance to exit from the operating roomIncidence of intraoperative respiratory depression

Secondary

MeasureTime frameDescription
Incidence of intraoperative hypotensionFrom entrance to exit from the operating roomMean blood pressure \<65 mmHg
Incidence of intraoperative hypertensionFrom entrance to exit from the operating roomSystolic blood pressure \>120% of baseline
Incidence of intraoperative bradycardiaFrom entrance to exit from the operating roomHeart rate \<45 bpm
Incidence of intraoperative tachycardiaFrom entrance to exit from the operating roomHeart rate \>120 bpm
Incidence of intraoperative oxygen desaturationFrom entrance to exit from the operating roomPulse oximeter saturation (SpO2) \< 93%
Incidence of intraoperative nausea or vomitingFrom entrance to exit from the operating roomNausea or vomiting during surgery
Incidence of intraoperative hiccupsFrom entrance to exit from the operating roomHiccups during surgery
Incidence of intraoperative paradoxical movementsFrom entrance to exit from the operating roomParadoxical movements during surgery
Modified Observer's Assessment of Alertness/Sedation (MOAA/S) scoreFrom start of remimazolam infusion until time of full alertnessMOAA/S score assessment at 10 min intervals
Total remimazolam infusion doseFrom start to end of remimazolam infusionTotal remimazolam infusion dose (mg/kg/h)
Time to reach MOAA/S score 5 after end of surgeryFrom end of remimazolam infusion until time of full alertnessTime to reach MOAA/S score 5 (min)
Length of stay at the post-anesthesia care unit (PACU)From entrance to exit from the PACULength of stay at the PACU (min)
Patient satisfactionAt exit from PACUNumeric rating scale of 0 (not satisfied at all) to 10 (absolutely satisfied)
Intraoperative recallAt exit from PACUAssessment with the modified Brice questionnaire
Incidence of postoperative nausea or vomitingFrom entrance to exit from the PACUIncidence of nausea or vomiting
Incidence of postoperative deliriumFrom end of surgery to third postoperative dayAssessment with the Confusion Assessment Method (CAM)
Incidence of postoperative respiratory depressionFrom entrance to exit from the PACURespiratory rate \< 8/min or SpO2\<93%
Incidence of postoperative hypotensionFrom entrance to exit from the PACUMean blood pressure \<65 mmHg
Incidence of postoperative hypertensionFrom entrance to exit from the PACUSystolic blood pressure \>120% from baseline
Intraoperative Patient State Index (PSi)From entrance to exit from the operating roomContinuous monitoring of PSi with Sedline sensor

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026